$9.56
+0.84%Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Acceptable margins but limited operational leverage. Operating expense control is important.
Moderate profitability with room for improvement. Monitor interest expenses and tax efficiency.
Higher tax burden may reflect limited tax optimization or operations in high-tax jurisdictions.
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
VMD โข NASDAQ
| Viemed Healthcare, Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||
270.3M | 224.3M | 183M | 138.8M | 117.1M | 131.3M | 80.3M | 65.3M | 46.9M | 31.4M | 34.6M | 23.3M | |
GROSS PROFIT | ||||||||||||
(116.3M) | (91.1M) | (70.2M) | (54.2M) | (43.7M) | (51.2M) | (24.3M) | (16.7M) | (12.3M) | (12.5M) | (7.8M) | (3.9M) | |
154M | 133.2M | 112.8M | 84.7M | 73.4M | 80.1M | 56M | 48.6M | 34.6M | 18.9M | 26.8M | 19.4M | |
OPERATING INCOME | ||||||||||||
(132.1M) | (115.3M) | (98.5M) | (76.4M) | (61.8M) | (53.3M) | (46.8M) | (31.5M) | (20.6M) | (14.1M) | (16.7M) | (9.9M) | |
(121.4M) | (112.5M) | (93.7M) | (73.4M) | (60M) | (57.7M) | (45.3M) | (30.9M) | (20.2M) | (13.8M) | (16.7M) | (9.6M) | |
(3M) | (3.1M) | (2.8M) | (2.7M) | (2.1M) | (1.1M) | (848K) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
21.8M | 17.9M | 14.3M | 8.3M | 11.6M | 26.8M | 8.7M | 17M | 8.8M | 383K | 10M | 9.5M | |
PRE-TAX INCOME | ||||||||||||
(1.2M) | (776K) | (424K) | (197K) | (318K) | (509K) | (314K) | (181K) | (272K) | (323K) | (0.0) | (0.0) | |
-1.2M | -776K | -424K | -197K | -318K | -509K | -314K | -181K | -272K | -323K | 0.0 | 0.0 | |
(7.8M) | -249K | (1.9M) | (369K) | -323K | -5.5M | (671K) | -71K | (402K) | (332K) | (0.0) | (0.0) | |
-67K | -1.7M | 61K | 738K | 923K | -418K | -61K | -386K | -633K | -274K | -87K | -34K | |
21.8M | 16.2M | 14.4M | 9M | 12.5M | 26.4M | 8.8M | 10.3M | 8.2M | 109K | 10M | 9.5M | |
NET INCOME | ||||||||||||
(6.4M) | (4.8M) | (4.1M) | (2.8M) | (3.4M) | -5.2M | (271K) | (162K) | (15K) | -1.1M | (1M) | (0.0) | |
14.9M | 11.3M | 10.2M | 6.2M | 9.1M | 31.5M | 8.5M | 10.2M | 8.2M | 1.2M | 8.9M | 9.5M |
VMD - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | June 02, 2026 | June 02, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 05, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 05, 2026 | May 05, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 22, 2026 | April 22, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 16, 2026 | March 16, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 04, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 04, 2026 | March 04, 2026 | 2026 | |
8-K 8-K 2025 N/A | November 07, 2025 | November 07, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 05, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 05, 2025 | November 05, 2025 | 2025 |
Continue your VMD research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.